Crestwood Advisors Group LLC lessened its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 9.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 297,679 shares of the semiconductor company's stock after selling 29,266 shares during the period. Crestwood Advisors Group LLC's holdings in Lam Research were worth $50,958,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of LRCX. Brighton Jones LLC lifted its holdings in shares of Lam Research by 1,032.4% in the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company's stock valued at $1,025,000 after purchasing an additional 12,936 shares in the last quarter. Caxton Associates LLP purchased a new position in shares of Lam Research during the first quarter valued at approximately $239,000. Gabelli Funds LLC purchased a new position in shares of Lam Research during the second quarter valued at approximately $253,000. NewEdge Advisors LLC lifted its stake in shares of Lam Research by 2.7% during the second quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company's stock valued at $9,785,000 after buying an additional 2,661 shares during the period. Finally, Osterweis Capital Management Inc. lifted its stake in shares of Lam Research by 5,206.7% during the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company's stock valued at $77,000 after buying an additional 781 shares during the period. Hedge funds and other institutional investors own 84.61% of the company's stock.
Insiders Place Their Bets
In other Lam Research news, SVP Neil J. Fernandes sold 18,170 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $255.14, for a total transaction of $4,635,893.80. Following the transaction, the senior vice president owned 66,129 shares of the company's stock, valued at $16,872,153.06. This trade represents a 21.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the transaction, the chief financial officer directly owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 120,066 shares of company stock valued at $27,953,242 over the last quarter. Company insiders own 0.31% of the company's stock.
Lam Research News Roundup
Here are the key news stories impacting Lam Research this week:
Analysts Set New Price Targets
LRCX has been the topic of several recent analyst reports. Barclays set a $275.00 price objective on shares of Lam Research and gave the company an "equal weight" rating in a research note on Thursday, April 23rd. Sanford C. Bernstein upped their price objective on shares of Lam Research from $285.00 to $325.00 and gave the company an "outperform" rating in a research note on Thursday, April 23rd. Argus upped their price objective on shares of Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. KeyCorp reissued a "sector weight" rating on shares of Lam Research in a research note on Thursday, January 29th. Finally, Weiss Ratings raised shares of Lam Research from a "buy (b-)" rating to a "buy (b)" rating in a research note on Friday, April 24th. Twenty-six research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and a consensus target price of $285.94.
Check Out Our Latest Analysis on Lam Research
Lam Research Stock Performance
NASDAQ:LRCX opened at $286.72 on Friday. The company has a quick ratio of 1.77, a current ratio of 2.54 and a debt-to-equity ratio of 0.35. The company has a market cap of $358.56 billion, a P/E ratio of 54.10, a P/E/G ratio of 2.46 and a beta of 1.81. Lam Research Corporation has a fifty-two week low of $74.65 and a fifty-two week high of $298.00. The firm's 50 day moving average is $238.93 and its two-hundred day moving average is $204.97.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. Lam Research's revenue was up 23.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Analysts expect that Lam Research Corporation will post 5.67 EPS for the current year.
Lam Research Company Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.